<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>6986</id><no>AGCT1532-NCT02582697</no><status>Open</status><title>Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours</title><secondary_protocol_no>AGCT1521</secondary_protocol_no><nct_id>NCT02582697</nct_id><sponsor_type>National</sponsor_type><age_group>Both</age_group><treatment_type>Treatment</treatment_type><phase>III</phase><disease_site>Ill-Defined Sites</disease_site><PI>Pudela, Caileigh</PI><oncology_group>Pediatrics<DOWG_name>Oncology Group</DOWG_name></oncology_group><management_group>Lombardi Comprehensive Cancer Center (LCCC)</management_group></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>